147 related articles for article (PubMed ID: 26544968)
1. The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers.
Watt DG; Proctor MJ; Park JH; Horgan PG; McMillan DC
PLoS One; 2015; 10(11):e0142159. PubMed ID: 26544968
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil count is the most important prognostic component of the differential white cell count in patients undergoing elective surgery for colorectal cancer.
Watt DG; Martin JC; Park JH; Horgan PG; McMillan DC
Am J Surg; 2015 Jul; 210(1):24-30. PubMed ID: 25842358
[TBL] [Abstract][Full Text] [Related]
3. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases.
Neal CP; Mann CD; Sutton CD; Garcea G; Ong SL; Steward WP; Dennison AR; Berry DP
Eur J Cancer; 2009 Jan; 45(1):56-64. PubMed ID: 18848775
[TBL] [Abstract][Full Text] [Related]
6. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.
Proctor MJ; McMillan DC; Horgan PG; Fletcher CD; Talwar D; Morrison DS
PLoS One; 2015; 10(3):e0116206. PubMed ID: 25730322
[TBL] [Abstract][Full Text] [Related]
8. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
9. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
Lin MS; Huang JX; Zhu J; Shen HZ
Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.
Golder AM; McMillan DC; Park JH; Mansouri D; Horgan PG; Roxburgh CS
Br J Cancer; 2021 May; 124(11):1828-1835. PubMed ID: 33762720
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
12. Acute bacterial infection negatively impacts cancer specific survival of colorectal cancer patients.
Attiê R; Chinen LT; Yoshioka EM; Silva MC; de Lima VC
World J Gastroenterol; 2014 Oct; 20(38):13930-5. PubMed ID: 25320529
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
14. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
15. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.
Proctor MJ; McMillan DC; Morrison DS; Fletcher CD; Horgan PG; Clarke SJ
Br J Cancer; 2012 Aug; 107(4):695-9. PubMed ID: 22828611
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.
Shin JS; Suh KW; Oh SY
J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893
[TBL] [Abstract][Full Text] [Related]
18. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
19. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer.
Sugimoto K; Komiyama H; Kojima Y; Goto M; Tomiki Y; Sakamoto K
Dig Surg; 2012; 29(6):503-9. PubMed ID: 23392422
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
